OpenVSafe by OpenVAERS
Search V-safe

EER-23381-40608

2 vaccinations 7 coded responses 24 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
240 / VA
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Registered in v-safe
  2. 2021-01-07
    Dose 1 — Moderna
  3. 2021-01-07
    Survey response — day 0, dose 1
    MedDRA: Abdominal pain, Headache, Nausea, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: I often have headache, nausea and abdominal pain, so this could be something not out of the ordinary.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  6. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains, Muscle or body aches
    Adult check-in
  7. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains
    Adult check-in
  8. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches
    Adult check-in
  9. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains, Muscle or body aches
    Adult check-in
  10. 2021-01-14
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Itching · Headache, Joint pains, Muscle or body aches
    Adult check-in
  11. 2021-01-21
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Moderate to severe itching, reddened, raised area around injection site of approximately 4 inches in diameter. · Healthcare visit (other): Emailed pictures to doctor.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-21
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-01-28
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-04
    Dose 2 — Moderna
  15. 2021-02-04
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  16. 2021-02-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion, Office visit, SARS-CoV-2 test — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Nasal congestion, · Healthcare visit (other): COVID testing to rule out infection, but doctor thinks it was a robust vaccine reaction.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-05
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-02-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-02-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nasal congestion — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  23. 2021-02-11
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  24. 2021-02-18
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-03-14
    Survey response — day 35, dose 2
    MedDRA: Condition aggravated, Dermatitis allergic, Dermatitis atopic, Pre-existing disease — Feeling: Fair
    Free text: Dermatological reaction to injectable medication that I have been taking for over 28 months without a reaction until this month. Worsening atopic dermatitis after the reaction to the injectable medication in another area of my body.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-03-20
    Survey response — day 42, dose 2
    MedDRA: Adverse drug reaction, Dermatitis — Feeling: Fair
    Free text: Dermatological reaction to injectable medication that I have been taking for over 2 years without any reaction. Reaction lasted 3 days. Did not have to immediately seek medical attention due to reaction.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-03-29
    Call successful
    Participant prefers to complete VAERS report online
  30. 2021-07-14
  31. 2022-02-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Moderna
22021-02-04Moderna

Call center

2 call center cases

1 successful · 1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 0, dose 1

2021-01-07

Systemic reaction (other): I often have headache, nausea and abdominal pain, so this could be something not out of the ordinary.

Release 2 — day 14, dose 1

2021-01-21

Symptoms: Moderate to severe itching, reddened, raised area around injection site of approximately 4 inches in diameter.
Healthcare visit (other): Emailed pictures to doctor.

Release 3 — days 1–6 daily, dose 2

2021-02-05

Systemic reaction (other): Nasal congestion,
Healthcare visit (other): COVID testing to rule out infection, but doctor thinks it was a robust vaccine reaction.

2021-02-06

Systemic reaction (other): Nasal congestion

2021-02-09

Systemic reaction (other): Nasal congestion

Release 5 — day 35, dose 2

2021-03-14

Symptoms: Dermatological reaction to injectable medication that I have been taking for over 28 months without a reaction until this month. Worsening atopic dermatitis after the reaction to the injectable medication in another area of my body.

Release 6 — day 42, dose 2

2021-03-20

Symptoms: Dermatological reaction to injectable medication that I have been taking for over 2 years without any reaction. Reaction lasted 3 days. Did not have to immediately seek medical attention due to reaction.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOSARS-CoV-2 test ✓ ✓ ✓
HCVOUnevaluable event ✓ ✓ ✓
SDAdverse drug reaction ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDermatitis ✓ ✓ ✓
SDDermatitis allergic ✓ ✓ ✓
SDDermatitis atopic ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SROAbdominal pain ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release